Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483)
- PMID: 32379935
- PMCID: PMC7267361
- DOI: 10.1111/jth.14890
Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483)
Comment in
-
The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.J Thromb Haemost. 2020 Aug;18(8):2068-2070. doi: 10.1111/jth.14941. J Thromb Haemost. 2020. PMID: 32495985 Free PMC article. No abstract available.
Comment on
-
Lupus anticoagulant is frequent in patients with Covid-19.J Thromb Haemost. 2020 Aug;18(8):2064-2065. doi: 10.1111/jth.14867. Epub 2020 May 11. J Thromb Haemost. 2020. PMID: 32324958 Free PMC article. No abstract available.
References
-
- Taylor F.B., Jr, Toh C.H., Hoots W.K., et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–1330. - PubMed
-
- Pengo V., Tripodi A., Reber G., et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009;7(10):1737–1740. - PubMed
-
- Ledford‐Kraemer M.M.G., Bottenus R., Brandt J.T., et al . Laboratory Testing for the Lupus Anticoagulant; Approved Guideline. CLSI document H60‐A. Clinical and Laboratory Standards Institute; Wayne, PA: 2014.
-
- Góralczyk T., Iwaniec T., Wypasek E., Undas A. False‐positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome. Blood Coagul Fibrinolysis. 2015;26(4):473–475. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
